TOP TIERMARKET NEWSWIRE

News & sentiment

ARMATA PHARMACEUTICA (ARMP) — News & AI sentiment

ARMATA PHARMACEUTICA (ARMP) news roundup. 7 stories aggregated over the last 30 days. Average 30-day sentiment is 60/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →

24h stories

0

7d stories

0

30d stories

7

avg sentiment 60/100

Insider net (90d)

$0

0 buys · 0 sells

Congress (90d)

0

0 buys · 0 sells

Latest stories on ARMP

Armata Shares Surge on Progress Toward Late-Stage Trial of Superbug Treatment

Morningstar73 · bullishproduct/pr

Jul 20

Armata Pharmaceuticals, Inc. (ARMP) files 8-K

SEC 8-K50 · neutralgeneral

Jul 20

Armata Pharmaceuticals Achieves Key Progress Across Clinical, Regulatory and Manufacturing Activities Supporting Planned Phase 3 Initiation of AP-SA02

StockTitan67 · bullishproduct/pr

Jul 20

Armata Pharmaceuticals: Promising Phage Platform, But Phase 3 Is Everything

Seeking Alpha50 · neutralgeneral

Jul 17

Armata Advances AP-SA02 Pediatric Plan With FDA Agreement

TipRanks63 · neutralgeneral

Jul 13

Armata Pharmaceuticals, Inc. (ARMP) files 8-K

SEC 8-K50 · neutralgeneral

Jul 13

Armata Pharmaceuticals Receives Agreement from FDA on Initial Pediatric Study Plan for AP-SA02 for the Treatment of Complicated Staphylococcus aureus Bacteremia

PR Newswire67 · bullishproduct/pr

Jul 13

8-K/A - Armata Pharmaceuticals, Inc. (ARMP) files 8-K

SEC 8-K50 · neutralgeneral

Jun 24

Armata gains $2.5M extra funding from DoD for lead program

Seeking Alpha63 · neutralgeneral

Jun 23

Armata Pharmaceuticals Shares Rise on Additional $2.5 Million Government Grant

Morningstar63 · neutralgeneral

Jun 23

Armata gains new DoD funding for AP-SA02 advancement

TipRanks63 · neutralgeneral

Jun 23

Armata Pharmaceuticals, Inc. (ARMP) files 8-K

SEC 8-K50 · neutralgeneral

Jun 23

Armata Pharmaceuticals Receives $2.5 Million of Additional Non-Dilutive Award Funding from the U.S. Department of Defense to Support AP-SA02

PR Newswire63 · neutralgeneral

Jun 23

Here’s Why Armata Pharmaceuticals Inc. (ARMP) is a High Growth Micro-Cap Stock to Buy?

Yahoo Top67 · bullishproduct/pr

Jun 19

Armata Pharmaceuticals, Inc. (ARMP) files 8-K

SEC 8-K50 · neutralgeneral

Jun 16

Armata Pharmaceuticals Announces First Quarter 2026 Results and Provides Corporate Update

PR Newswire55 · neutralgeneral

May 13

Armata Pharmaceuticals Secures FDA Fast Track Designation for AP-SA02

PR Newswire73 · bullishproduct/pr

May 7

Open ARMP in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →